WHSC1L1 Antibody
-
中文名稱：WHSC1L1兔多克隆抗體
-
貨號：CSB-PA880145LA01HU
-
規格：￥440
-
圖片：
-
Immunohistochemistry of paraffin-embedded human ovarian cancer using CSB-PA880145LA01HU at dilution of 1:100
-
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) NSD3 Polyclonal antibody
-
Uniprot No.：
-
基因名：NSD3
-
別名：DKFZp667H044 antibody; FLJ20353 antibody; Histone lysine N methyltransferase NSD3 antibody; Histone-lysine N-methyltransferase NSD3 antibody; MGC126766 antibody; MGC142029 antibody; NSD 3 antibody; NSD3_HUMAN antibody; Nuclear set domain containing 3 antibody; Nuclear SET domain containing protein 3 antibody; Nuclear SET domain-containing protein 3 antibody; pp14328 antibody; Protein whistle antibody; Whistle antibody; WHSC1 like protein 1 antibody; WHSC1-like 1 isoform 9 with methyltransferase activity to lysine antibody; WHSC1-like protein 1 antibody; WHSC1L1 antibody; WHSC1L1 protein antibody; Wolf Hirschhorn syndrome candidate 1 like 1 antibody; Wolf-Hirschhorn syndrome candidate 1-like protein 1 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human Histone-lysine N-methyltransferase NSD3 protein (1-645AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
本頁面中的產品，WHSC1L1 Antibody (CSB-PA880145LA01HU)，的標記方式是Non-conjugated。對于WHSC1L1 Antibody，我們還提供其他標記。見下表：
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產品提供形式：Liquid
-
應用范圍：ELISA, IHC
-
推薦稀釋比：
Application Recommended Dilution IHC 1:20-1:200 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Histone methyltransferase. Preferentially dimethylates 'Lys-4' and 'Lys-27' of histone H3 forming H3K2me2 and H3K27me2. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation, while 'Lys-27' is a mark for transcriptional repression.
-
基因功能參考文獻：
- Studies showed that depletion of NSD3 in osteosarcoma cell lines inhibited cell proliferation and survival, and induced cell apoptosis. RNA sequence analysis of tumor cell lines with NSD3 deletion revealed that NSD3 functions as either a transcriptional activator or a repressor. These results suggest that NSD3 may function as an oncogenic driver in osteosarcoma. PMID: 28901481
- Results extend the in vitro results and show that targeted expression of NSD3 to the mammary gland of FVB mice is oncogenic, consistent with the hypothesis that NSD3 is an important driver oncogene in human breast cancer. PMID: 28484924
- WHSC1L1 and H3K36me2 are enriched in the gene bodies of the cell cycle-related genes CDC6 and CDK2, implying that WHSC1L1 directly regulates the transcription of these gene PMID: 27285764
- This study demonstrates that over-expression of WHSC1L1 is linked to over-expression of ER-alpha in SUM-44 breast cancer cells and in primary human breast cancers. PMID: 27005559
- Studies indicate that the NSD methyltransferases NSD1, NSD2/WHSC1/MMSET and NSD3/WHSC1L1 were overexpressed, amplified or somatically mutated in multiple types of cancer, suggesting their critical role in cancer. PMID: 25942451
- Results demonstrate that the AML maintenance function of BRD4 requires its interaction with the short isoform of NSD3 lacking the methyltransferase domain. This protein is an adaptor that sustains leukemia by linking BRD4 to the CHD8 chromatin remodeler. PMID: 26626481
- The results describe the binding of NSD1, 2 and 3 catalytic domains (CD) on histone tails through recognition of histone-lysine and methylation properties. PMID: 25494638
- The involvement of the NSD3 methyltransferase as a component of the NUT fusion protein oncogenic complex identifies a new potential therapeutic target. PMID: 24875858
- PPAPDC1B and WHSC1L1 played a major role in regulating the survival of breast cancer, pancreatic adenocarcinoma and small-cell lung cancer-derived cell lines. PMID: 24051013
- Data indicate that siRNA attenuated the expression levels of CCNG1 and NEK7, implying that WHSC1L1 appears to activate the expression of CCNG1 and NEK7 in cancer cells. PMID: 23011637
- methyltransferase NSD3 has chromatin-binding motifs, PHD5-C5HCH, that are distinct from other NSD (nuclear receptor SET domain) family members in their histone H3 recognition PMID: 23269674
- Functional studies with Brd4 indicate that the ET domain mediates pTEFb-independent transcriptional activation through a subset of these associated factors, including NSD3. PMID: 21555454
- Overexpression of WHSC1L1 gene is associated with breast cancer. PMID: 20940404
- NSD3L depletion increased the invasiveness of MDA-MB-231 breast cancer cells indicating that NSD3L normally restrain cellular metastatic potential. Together the presented data indicates that NSD3L is a candidate tumor suppressor. PMID: 20599755
顯示更多
收起更多
-
相關疾病：Defects in NSD3 may be involved in non small cell lung carcinomas (NSCLC). Amplified or overexpressed in NSCLC.
-
亞細胞定位：Nucleus. Chromosome.
-
蛋白家族：Class V-like SAM-binding methyltransferase superfamily, Histone-lysine methyltransferase family, SET2 subfamily
-
組織特異性：Highly expressed in brain, heart and skeletal muscle. Expressed at lower level in liver and lung.
-
數據庫鏈接：
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
